Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1700000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of warrants with exercise price adjustment clauses (monthly report)
発行・処分する株式数
Shares delivered during the month: 1,700,000 shares (1,700,000 new shares and 0 treasury shares transferred)
発行済株式総数
1,700,000 shares delivered during the month; 397,134,550 shares issued and outstanding at the end of the previous month
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment clause. The exercise price during the reporting month was ¥45.0–¥48.6.
Number of Stock Acquisition Rights
Total number issued: Not disclosed; exercised during the month: 17,000; unexercised at the end of the previous month: 854,171; unexercised at the end of the reporting month: 837,171
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
25 November 2025: Issuance of Series 46 warrants with exercise price adjustment clauses. Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of warrants with exercise price adjustment clauses (monthly report) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 1,700,000 shares (1,700,000 new shares and 0 treasury shares transferred) |
| Dilution Rate | 1,700,000 shares delivered during the month; 397,134,550 shares issued and outstanding at the end of the previous month |
| Total number of issued shares | 397,134,550 shares (at the end of the month preceding the reporting month) → Not disclosed |
| Exercise price | Subject to an exercise price adjustment clause. The exercise price during the reporting month was ¥45.0–¥48.6. |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed; exercised during the month: 17,000; unexercised at the end of the previous month: 854,171; unexercised at the end of the reporting month: 837,171 |
| Procedures under the Corporate Code of Conduct | Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | 25 November 2025: Issuance of Series 46 warrants with exercise price adjustment clauses. Amount: Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in May 2026 of the Series 46 warrants with exercise price adjustment clauses issued on 25 November 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.